Uncover the potential link between the widely used antibiotic cefepime and neurotoxicity in patients, particularly those with renal impairment, and understand how timely monitoring and management of cefepime levels could prove to be a vital aspect of patient care.

The FDA’s approval of Beyfortus offers a promising tool for RSV disease prevention in neonates and young children. This novel intervention, underscored by robust clinical trial data, marks a crucial stride towards protecting infant health in the US.

Brenzavvy, the latest addition to the diabetes treatment landscape, promises a cost-effective approach to managing type 2 diabetes. Discover how this newly approved drug could redefine the treatment paradigm for patients.

With the resurgence of gout in individuals over 30, it’s important to recognize its primary triggers and symptoms for early diagnosis and management, ensuring this treatable form of arthritis doesn’t lead to long-term damage in patients.

Explore the unmasking of postural orthostatic tachycardia syndrome (POTS) amid the COVID-19 pandemic and its vaccine era, with the integration of traditional and alternative treatments offering renewed hope for affected patients.

With a growing debate around the British Journal of Psychiatry’s decision not to retract a controversial abortion paper, we invite you to delve deeper into the ensuing implications for scientific publication standards and the interplay between science, politics, and law.